Service users’ participation in mental health community-based organizations

Une grande proportion de personnes aux prises avec des problèmes de santé mentale vit dans l’isolement social. Les infirmières en santé communautaire sont interpellées au premier rang pour accompagner ces personnes dans leur processus de rétablissement et pour atténuer leur isolement social. La participation au sein d’organismes communautaires optimise l’expérience de rétablissement, diminue l’isolement social et renforce les réseaux sociaux de personnes ayant des problèmes de santé mentale. Toutefois, la participation des personnes utilisatrices de services dans la structure d’organisation des organismes communautaires est encore peu documentée. Afin de pallier cette lacune, cette étude avait pour objectifs de documenter, décrire la nature de la participation des personnes utilisatrices de services en santé mentale et d’explorer des facteurs facilitatants et des barrières à cette participation. Un devis de méthodes mixtes, qualitatif et quantitatif, a été utilisé. Dans le premier de deux volets, une enquête impliquant la réalisation d’entretiens semi-dirigés a été menée auprès de douze directeurs d’organismes communautaires œuvrant dans le domaine des services en santé mentale. Une version française du questionnaire « Adapted User Involvement » (Diamond, Parkin, Morris, Bettinis, & Bettesworth, 2003) a été administrée afin de documenter l’étendue de la participation des personnes utilisatrices de services dans les organismes visés. Pour le deuxième volet, deux organismes communautaires ont été sélectionnés à partir des résultats du questionnaire et de l’analyse documentaire de documents publics de ces organismes. Les scores obtenus au questionnaire ont ainsi permis de sélectionner des organismes présentant des résultats contrastés en matière de participation des personnes utilisatrices de services. Les entretiens semi-dirigés ont été menés avec différents groupes de répondants (membres de conseil d’administration, personnes utilisatrices de services, employés, directeurs) afin de recueillir de l’information sur les thèmes suivants: la nature de la participation des personnes utilisatrices de services, ainsi que les facteurs facilitants et les défis qui y sont associés. Les résultats de l’analyse montrent que: (1) les facteurs qui favorisent la participation des personnes utilisatrices sont: l’accès à un espace de participation pour les personnes utilisatrices et l’accompagnement de celles-ci par les intervenants de diverses disciplines pendant leur participation au sein des organismes communautaires, (2) les barrières de la participation des personnes utilisatrices au sein des organismes communautaires sont la stigmatisation sociale et les caractéristiques personnelles reliées aux problèmes de santé mentale chez les personnes utilisatrices, et (3) les avantages principaux de la participation des personnes utilisatrices de services se déclinent en services mieux adaptés à leurs besoins et leurs demandes, en leur appropriation du pouvoir (dans leur participation dans l’organisme communautaire) et en leur sentiment d’appartenance à l’organisme. À la lumière des ces constats, l’accompagnement des personnes utilisatrices de services dans leur participation apparaît une avenue prometteuse pour les infirmières en santé mentale communautaire afin de faciliter leur appropriation du pouvoir et d’améliorer leur bien-être.A large proportion of individuals with mental health problems are affected by social isolation. In the front line, community mental health nurses are called upon to accompany these individuals in their recovery process, and reduce their social isolation. User participation in community-based organizations (CBO) optimizes the recovery process, decreases feelings of social isolation, and consolidates the social support networks of individuals living with mental health problems. However, relatively little is documented on user participation within the organizational structure of mental health CBOs. To address this knowledge gap, the objectives of this study were to document, describe the nature of user participation and explore facilitating and inhibiting factors associated with user participation. A mixed-method (qualitative and quantitative) design, broken into two phases, was used in this study. In the first phase, a survey of twelve directors from CBOs providing services to individuals with mental health problems was conducted using the format of semi-structured interviews. The French version of the “Adapted User Involvement Questionnaire” (Diamond et al., 2003) was administered in order to document the extent of user participation in the targeted CBOs. In the second phase, two CBOs were selected on the basis of the results of the questionnaire and the findings of the archival data analysis. The scores obtained by the administration of this questionnaire made it possible to choose CBOs with constrasting results on user participation. Different groups of key informants (members of the governing board of the CBO, service users, CBO staff and directors) from the two CBOs participated in semi-structured interviews to collect detailed information about the following themes: the nature of user participation and facilitators and inhibitors for user participation. Results of the analysis show that: (1) factors that facilitate user participation are : access to participatory space for service users and professionals of different disciplines supporting service users in user participation activities; (2) factors that inhibit user participation are : social stigmatization of individuals with mental health problems and service users’ personal characteristics associated with their mental health problems; and (3) advantages of user participation are: services adapted to users’ needs and requests, service user empowerment (in participating in organization of CBO services) and service users’ sense of belonging to the CBO. Consequently, the study’s findings suggest that accompanying service users in their participation in CBOs, in order to facilitate their empowerment and improve their well-being, is a promising avenue for community mental-health nurses

Effects of steel corrosion to BFRP Strengthened columns under eccentric loading

The experiment consists of twenty-four mid-scale rectangular RC columns (200x200x800mm) strengthening by BFRP sheets and research variables include: BFRP layer (0, 1, and 3 layers); eccentricity (25mm and 75mm); and 4 levels of steel corrosion. The results reveal that SEL (ratio of ultimate load of strengthened member to that of corresponding controlled member) is direct proportion with steel corrosion while SEV (ratio of ultimate vertical displacement of strengthened member to that of corresponding controlled member) is inverse proportion with steel corrosion; SEL slightly increases with the increase of BFRP layer and eccentricity; but SEV decreases noticeably with the increase of BFRP layer and eccentricity. In addition,the interaction between FRP sheets, stirrups, and longitudinal reinforcement in steel degraded BFRP strengthened columns is very strong.However, column design basing on current design manuals and codes as ACI 440.2R and CNR DT 200R1 has not mentioned this affect. Thus, the load capacity prediction of column being strengthened by BFRP sheets should include levels of steel corrosion for reality, reasonable, and integral of the design

Effects of steel corrosion to BFRP Strengthened columns under eccentric loading

The experiment consists of twenty-four mid-scale rectangular RC columns (200x200x800mm) strengthening by BFRP sheets and research variables include: BFRP layer (0, 1, and 3 layers); eccentricity (25mm and 75mm); and 4 levels of steel corrosion. The results reveal that SEL (ratio of ultimate load of strengthened member to that of corresponding controlled member) is direct proportion with steel corrosion while SEV (ratio of ultimate vertical displacement of strengthened member to that of corresponding controlled member) is inverse proportion with steel corrosion; SEL slightly increases with the increase of BFRP layer and eccentricity; but SEV decreases noticeably with the increase of BFRP layer and eccentricity. In addition,the interaction between FRP sheets, stirrups, and longitudinal reinforcement in steel degraded BFRP strengthened columns is very strong.However, column design basing on current design manuals and codes as ACI 440.2R and CNR DT 200R1 has not mentioned this affect. Thus, the load capacity prediction of column being strengthened by BFRP sheets should include levels of steel corrosion for reality, reasonable, and integral of the design

Synthesis of 2,7,8-trioxaspiro[4,5]decan-1-ones by manganese(III)-based reaction

Some new spiro bicyclic compounds possessing one 1,2-dioxane ring and one γ-lactone ring were successfully synthesized by manganese(III)-based reaction of 1,1-diarylethenes and 2-acetylbutyrolactone under air. The procedure was simple and the product yield was high.   The NMR spectrometric features of the products were analyzed and the reaction mechanism is briefly discussed. Keywords. Manganese(III)-based reaction, spiro bicyclic compound, 1,2-dioxane ring, γ-lactone ring

A preliminary study to establish the transfected CHO cell lines which highly express Trastuzumab - A biosimilar product of Herceptin

Human epidermal growth factor receptor 2 (HER2) has been identified as a molecular target for breast cancer therapy, such as Trastuzumab (Herceptin®). This has been shown to improve patient survival substantially. The current study is aiming to locally produce an anti-HER2 monoclonal antibody (named Trastuzumab) which has an equivalent biological properties in comparison with the original version, Herceptin®). In silico design and construction of recombinant vectors, as well as the establishment of transfected cell lines with high expression of Trastuzumab were performed. Based on the protein sequences obtained from the Drugbank, the DNA sequences encoding for the light chain (Tras-Lc) and heavy chain (Tras-Hc) of Trastuzumab were optimized and integrated into pNanogen-Hygro and pNanogen-Puro vectors, respectively. The Neon Transfection System was used to co-transfect the pNanogen-Tras-Lc-Hygro and pNanogen-Tras-Hc-Puro constructs into CHO cells. Different co-transfected single-cell-colonies selected on media supplemented with hygromycin and puromycin were used for ELISA and SDS-PAGE assays to identify the CHO cell lines which highly express Trastuzumab. Based on the present results, 30μg of both constructs were suitable for DNA co-transfection. After 07 days of culture, the highest amount of Trastuzumab (561 µg/ml) was obtained from the H06LD68 cell line

THÀNH PHẦN HÓA HỌC VÀ HOẠT TÍNH KHÁNG VI SINH VẬT GÂY BỆNH CỦA TINH DẦU TỪ VỎ BƯỞI DA XANH (Citrus maxima (Burm.) Merr.)

Pomelo is a Vietnam’s plant species with high nutritional and economic value. Besides, pomelo essential oil contains numerous compounds with high biological activity. The essential oil is extracted by using steam distillation, and its chemical composition is determined by means of GC-MS. The major components are limonene (91.19%), b-myrcene (2.92%), a-phellandrene (1.98%), and a-pinene (1.19%). The antimicrobial activity of essential oils is tested against pathogenic Gram-positive bacteria (Bacillus cereus, Staphylococcus aureus), Gram-negative bacteria (Escherichia coli), and Aspergillus flavus at different concentrations with the agar well diffusion method. This essential oil is active against B. cereus, S. aureus, and E. coli with inhibition diameter zones at 8.3–11.3, 10.3–18.7, and 9.0–11.7 mm, respectively, and inhibits A. flavus mold with 18.9–65.0% efficiency.Bưởi là loài cây không chỉ có giá trị cao về mặt dinh dưỡng mà còn có giá trị cao về mặt kinh tế và được trồng phổ biến ở Việt Nam. Ngoài ra, tinh dầu bưởi chứa nhiều hợp chất có hoạt tính sinh học cao. Tinh dầu bưởi được chiết xuất bằng phương pháp chưng cất lôi cuốn hơi nước và thành phần hóa học được phân tích bằng phương pháp GC-MS. Thành phần chính của tinh dầu gồm limonene (91,19%), b-myrcene (2,92%), a-phellandrene (1,98%) và a-pinene (1,19%). Hoạt tính kháng vi sinh vật của tinh dầu được khảo sát với vi khuẩn Gram dương (Bacillus cereus, Staphylococcus aureus), Gram âm (Escherichia coli) và nấm mốc Aspergillus flavus ở nồng độ 5, 10, 25 và 50% bằng phương pháp khuếch tán giếng thạch. Tinh dầu có khả năng kháng B. cereus, S. aureus và E. coli với đường kính vòng kháng khuẩn lần lượt là 8,3–11,3, 10,3–18,7 và 9,0–11,7 mm và ức chế sự phát triển của A. flavus (18,9–65,0%)

Awareness and preparedness of healthcare workers against the first wave of the COVID-19 pandemic: A cross-sectional survey across 57 countries.

BACKGROUND: Since the COVID-19 pandemic began, there have been concerns related to the preparedness of healthcare workers (HCWs). This study aimed to describe the level of awareness and preparedness of hospital HCWs at the time of the first wave. METHODS: This multinational, multicenter, cross-sectional survey was conducted among hospital HCWs from February to May 2020. We used a hierarchical logistic regression multivariate analysis to adjust the influence of variables based on awareness and preparedness. We then used association rule mining to identify relationships between HCW confidence in handling suspected COVID-19 patients and prior COVID-19 case-management training. RESULTS: We surveyed 24,653 HCWs from 371 hospitals across 57 countries and received 17,302 responses from 70.2% HCWs overall. The median COVID-19 preparedness score was 11.0 (interquartile range [IQR] = 6.0-14.0) and the median awareness score was 29.6 (IQR = 26.6-32.6). HCWs at COVID-19 designated facilities with previous outbreak experience, or HCWs who were trained for dealing with the SARS-CoV-2 outbreak, had significantly higher levels of preparedness and awareness (p<0.001). Association rule mining suggests that nurses and doctors who had a 'great-extent-of-confidence' in handling suspected COVID-19 patients had participated in COVID-19 training courses. Male participants (mean difference = 0.34; 95% CI = 0.22, 0.46; p<0.001) and nurses (mean difference = 0.67; 95% CI = 0.53, 0.81; p<0.001) had higher preparedness scores compared to women participants and doctors. INTERPRETATION: There was an unsurprising high level of awareness and preparedness among HCWs who participated in COVID-19 training courses. However, disparity existed along the lines of gender and type of HCW. It is unknown whether the difference in COVID-19 preparedness that we detected early in the pandemic may have translated into disproportionate SARS-CoV-2 burden of disease by gender or HCW type

Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial

Background Trials of fluoxetine for recovery after stroke report conflicting results. The Assessment oF FluoxetINe In sTroke recoverY (AFFINITY) trial aimed to show if daily oral fluoxetine for 6 months after stroke improves functional outcome in an ethnically diverse population. Methods AFFINITY was a randomised, parallel-group, double-blind, placebo-controlled trial done in 43 hospital stroke units in Australia (n=29), New Zealand (four), and Vietnam (ten). Eligible patients were adults (aged ≥18 years) with a clinical diagnosis of acute stroke in the previous 2–15 days, brain imaging consistent with ischaemic or haemorrhagic stroke, and a persisting neurological deficit that produced a modified Rankin Scale (mRS) score of 1 or more. Patients were randomly assigned 1:1 via a web-based system using a minimisation algorithm to once daily, oral fluoxetine 20 mg capsules or matching placebo for 6 months. Patients, carers, investigators, and outcome assessors were masked to the treatment allocation. The primary outcome was functional status, measured by the mRS, at 6 months. The primary analysis was an ordinal logistic regression of the mRS at 6 months, adjusted for minimisation variables. Primary and safety analyses were done according to the patient's treatment allocation. The trial is registered with the Australian New Zealand Clinical Trials Registry, ACTRN12611000774921. Findings Between Jan 11, 2013, and June 30, 2019, 1280 patients were recruited in Australia (n=532), New Zealand (n=42), and Vietnam (n=706), of whom 642 were randomly assigned to fluoxetine and 638 were randomly assigned to placebo. Mean duration of trial treatment was 167 days (SD 48·1). At 6 months, mRS data were available in 624 (97%) patients in the fluoxetine group and 632 (99%) in the placebo group. The distribution of mRS categories was similar in the fluoxetine and placebo groups (adjusted common odds ratio 0·94, 95% CI 0·76–1·15; p=0·53). Compared with patients in the placebo group, patients in the fluoxetine group had more falls (20 [3%] vs seven [1%]; p=0·018), bone fractures (19 [3%] vs six [1%]; p=0·014), and epileptic seizures (ten [2%] vs two [<1%]; p=0·038) at 6 months. Interpretation Oral fluoxetine 20 mg daily for 6 months after acute stroke did not improve functional outcome and increased the risk of falls, bone fractures, and epileptic seizures. These results do not support the use of fluoxetine to improve functional outcome after stroke